PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MEDIROM Healthcare Technologies Inc. (MRM)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS58510H1032
CUSIP58510H103
SectorConsumer Cyclical
IndustryPersonal Services

Highlights

Market Cap$29.69M
EPS-$0.05
PE Ratio30.11
Revenue (TTM)$7.05B
Gross Profit (TTM)$1.42B
EBITDA (TTM)$134.90M
Year Range$3.50 - $7.40
Target Price$169.22
Short %0.33%
Short Ratio3.80

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


MEDIROM Healthcare Technologies Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in MEDIROM Healthcare Technologies Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-80.00%-60.00%-40.00%-20.00%0.00%20.00%40.00%NovemberDecember2024FebruaryMarchApril
-60.36%
36.05%
MRM (MEDIROM Healthcare Technologies Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

MEDIROM Healthcare Technologies Inc. had a return of 4.72% year-to-date (YTD) and 10.93% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date4.72%6.30%
1 month-3.39%-3.13%
6 months5.64%19.37%
1 year10.93%22.56%
5 years (annualized)N/A11.65%
10 years (annualized)N/A10.55%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20244.90%-0.50%2.85%
202314.46%-6.75%-11.13%19.42%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of MRM is 58, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.

The Risk-Adjusted Performance Rank of MRM is 5858
MEDIROM Healthcare Technologies Inc.(MRM)
The Sharpe Ratio Rank of MRM is 5959Sharpe Ratio Rank
The Sortino Ratio Rank of MRM is 5959Sortino Ratio Rank
The Omega Ratio Rank of MRM is 5959Omega Ratio Rank
The Calmar Ratio Rank of MRM is 5858Calmar Ratio Rank
The Martin Ratio Rank of MRM is 5757Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for MEDIROM Healthcare Technologies Inc. (MRM) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


MRM
Sharpe ratio
The chart of Sharpe ratio for MRM, currently valued at 0.25, compared to the broader market-2.00-1.000.001.002.003.000.25
Sortino ratio
The chart of Sortino ratio for MRM, currently valued at 0.81, compared to the broader market-4.00-2.000.002.004.006.000.81
Omega ratio
The chart of Omega ratio for MRM, currently valued at 1.11, compared to the broader market0.501.001.501.11
Calmar ratio
The chart of Calmar ratio for MRM, currently valued at 0.16, compared to the broader market0.001.002.003.004.005.000.16
Martin ratio
The chart of Martin ratio for MRM, currently valued at 0.59, compared to the broader market0.0010.0020.0030.000.59
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.92, compared to the broader market-2.00-1.000.001.002.003.001.92
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.78, compared to the broader market-4.00-2.000.002.004.006.002.78
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.33, compared to the broader market0.501.001.501.33
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.47, compared to the broader market0.001.002.003.004.005.001.47
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.64, compared to the broader market0.0010.0020.0030.007.64

Sharpe Ratio

The current MEDIROM Healthcare Technologies Inc. Sharpe ratio is 0.25. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
0.25
1.92
MRM (MEDIROM Healthcare Technologies Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


MEDIROM Healthcare Technologies Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2024FebruaryMarchApril
-65.46%
-3.50%
MRM (MEDIROM Healthcare Technologies Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the MEDIROM Healthcare Technologies Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the MEDIROM Healthcare Technologies Inc. was 78.72%, occurring on Dec 19, 2023. The portfolio has not yet recovered.

The current MEDIROM Healthcare Technologies Inc. drawdown is 65.46%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-78.72%Jan 11, 2021739Dec 19, 2023
-7.35%Dec 30, 20205Jan 6, 20212Jan 8, 20217

Volatility

Volatility Chart

The current MEDIROM Healthcare Technologies Inc. volatility is 4.62%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%NovemberDecember2024FebruaryMarchApril
4.62%
3.58%
MRM (MEDIROM Healthcare Technologies Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of MEDIROM Healthcare Technologies Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items